13F-HR filed by Alphabet Inc.
Alphabet Inc. filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 51 holding rows worth $1,721,793,620.
- Accession
- 0001652044-23-000026
- Filer
- CIK 1652044
- Filed
- 2023-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 61 entries on the cover page, a total value of $1,721,793,620 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,721,793,620 with VALUE read as dollars as filed, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerGV Management Company, L.L.C.028-22704
- included managerCapitalG Rise LLC028-22709
- included managerCapitalG LP028-22707
- included managerGoogle LLC028-22705
- included managerCapitalG II LP028-22706
- included managerVerily Life Sciences LLC028-22703
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRIME MEDICINE INC | 74168J101 | COM | 13,284,688 | $246,829,503 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 10,549,086 | $204,124,814 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 14,068,674 | $178,812,847 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 1,250,000 | $141,550,000 | dollars as filed | |
| PLANET LABS PBC | 72703X106 | COM CL A | 31,942,641 | $138,950,488 | dollars as filed | |
| EQRX INC | 26886C107 | COM | 47,675,476 | $117,281,671 | dollars as filed | |
| SNOWFLAKE INC COM SHS | 833445109 | Stock | 535,604 | $76,880,598 | dollars as filed | |
| CROWDSTRIKE HLDGS INC | 22788C105 | COM | 622,073 | $65,498,066 | dollars as filed | |
| FRESHWORKS INC CLASS A COM | 358054104 | Stock | 4,035,595 | $59,363,603 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 24,042,864 | $59,145,444 | dollars as filed | |
| GITLAB INC CLASS A COM | 37637K108 | Stock | 1,294,527 | $58,823,307 | dollars as filed | |
| LYFT INC | 55087P104 | CL A COM | 5,257,563 | $57,938,344 | dollars as filed | |
| DUOLINGO INC CL A COM | 26603R106 | Stock | 704,444 | $50,107,102 | dollars as filed | |
| ROBINHOOD MKTS INC | 770700102 | COM | 4,928,535 | $40,118,275 | dollars as filed | |
| BENSON HILL INC | 082490103 | COM | 15,352,271 | $39,658,291 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,568,753 | $23,437,170 | dollars as filed | |
| LYELL IMMUNOPHARMA INC | 55083R104 | COM | 5,865,125 | $20,351,984 | dollars as filed | |
| DESKTOP METAL INC | 25058X105 | COM CL A | 11,048,730 | $15,026,273 | dollars as filed | |
| 23ANDME HOLDING CO | 90138Q108 | CLASS A COM | 6,736,785 | $14,551,456 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 321,604 | $12,577,932 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,464,015 | $11,141,154 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 2,812,500 | $11,109,375 | dollars as filed | |
| ILLUMINA INC | 452327109 | COM | 53,470 | $10,811,634 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 540,270 | $10,697,346 | dollars as filed | |
| INVIVYD INC | 00534A102 | COMMON STOCK | 5,680,785 | $8,521,178 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 301,580 | $5,835,573 | dollars as filed | |
| NEW RELIC INC | 64829B100 | COMMON STOCK | 91,132 | $5,144,401 | dollars as filed | |
| BARINTHUS BIOTHERAPEUTICS PL | 91864C107 | ADS | 1,513,644 | $3,557,063 | dollars as filed | |
| DECIBEL THERAPEUTICS INC | 24343R106 | COM | 1,636,258 | $3,354,329 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 500,901 | $3,195,748 | dollars as filed | |
| RANI THERAPEUTICS HLDGS INC | 753018100 | CMN | 510,128 | $3,009,755 | dollars as filed | |
| KRONOS BIO INC | 50107A104 | COM | 1,438,232 | $2,329,936 | dollars as filed | |
| AMPLITUDE INC COM CL A | 03213A104 | Stock | 189,447 | $2,288,520 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 255,452 | $1,859,690 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 915,705 | $1,840,567 | dollars as filed | |
| EVELO BIOSCIENCES INC | 299734103 | COM | 1,060,495 | $1,707,397 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 1,077,080 | $1,647,932 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 175,866 | $1,623,243 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 889,979 | $1,539,664 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 640,882 | $1,448,393 | dollars as filed | |
| SCIENCE 37 HOLDINGS INC | 808644108 | COM | 3,207,260 | $1,347,049 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 3,339,138 | $1,335,655 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 698,262 | $1,326,698 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 23,205 | $1,148,880 | dollars as filed | |
| VELO3D INC | 92259N104 | COM | 572,400 | $1,024,596 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 898,720 | $754,925 | dollars as filed | |
| OPORTUN FINANCIAL CORP | 68376D104 | COMMON STOCK | 94,788 | $522,282 | dollars as filed | |
| INVITAE CORP | 46185L103 | COM | 215,965 | $401,695 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 189,122 | $121,038 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 383 | $64,846 | dollars as filed | |
| CUE HEALTH INC | 229790100 | COM | 27,000 | $55,890 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001652044-23-000026 | this filing | 2023-02-14 | acceptance time not in the bulk data set |